Painful Bladder Syndrome
42
4
5
24
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
13 trials with published results (31%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
14.3%
6 terminated out of 42 trials
80.0%
-6.5% vs benchmark
24%
10 trials in Phase 3/4
54%
13 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (42)
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS
URACYST® For the Treatment of GAG Deficient Interstitial Cystitis
Physiotherapeutic Interventions Applied to the Bladder Pain Syndrome
Physical Therapy Trial for Pelvic Pain
Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder
Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial
Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC
Physical Therapy in Women With Interstitial Cystitis
Diagnostic Challenges in IC (and Male CPPS)
Genetics of Interstitial Cystitis
Prospective Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of PBS/Interstitial Cystitis
Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)